278 related articles for article (PubMed ID: 16908080)
1. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
[No Abstract] [Full Text] [Related]
2. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion.
Takebayashi H; Kobayashi Y; Dangas G; Fujii K; Mintz GS; Stone GW; Moses JW; Leon MB
Catheter Cardiovasc Interv; 2003 Dec; 60(4):496-9. PubMed ID: 14624428
[TBL] [Abstract][Full Text] [Related]
3. Stent fracture and restenosis in the drug-eluting stent era.
Sianos G; Hofma S; Ligthart JM; Saia F; Hoye A; Lemos PA; Serruys PW
Catheter Cardiovasc Interv; 2004 Jan; 61(1):111-6. PubMed ID: 14696169
[No Abstract] [Full Text] [Related]
4. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management?
Kim EJ; Rha SW; Wani SP; Suh SY; Choi CU; Kim JW; Park CG; Seo HS; Oh DJ
Int J Cardiol; 2007 Sep; 120(3):417-9. PubMed ID: 17084924
[TBL] [Abstract][Full Text] [Related]
5. Late incomplete lesion coverage following Cypher stent deployment for diffuse right coronary artery stenosis.
Halkin A; Carlier S; Leon MB
Heart; 2004 Aug; 90(8):e45. PubMed ID: 15253987
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
[TBL] [Abstract][Full Text] [Related]
7. Fractured DES with a patent coronary artery: clinical implications.
Park JS; Shin DG; Kim YJ
J Invasive Cardiol; 2007 Feb; 19(2):E43-5. PubMed ID: 17268051
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
Mixon T; Fitzsimmons P
J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
[No Abstract] [Full Text] [Related]
9. Treatment of restenosis after bare-metal and drug-eluting stenting of an aorto-ostial lesion: challenges associated with excessive stent overhang.
Kunadian B; Vijayalakshmi K; de Belder MA
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):744-7. PubMed ID: 17700411
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus-eluting stents: does a great stent still need a good interventionalist?
Carrozza JP
J Am Coll Cardiol; 2004 Mar; 43(6):1116-7. PubMed ID: 15028376
[No Abstract] [Full Text] [Related]
11. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
Beijk MA; Piek JJ
Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
[TBL] [Abstract][Full Text] [Related]
12. Restenosis of a sirolimus drug-eluting stent: aorto-ostial involvement of the proximal right coronary artery.
Applegate RJ; Draughn T; Yarbrough WD; Little WC
Catheter Cardiovasc Interv; 2006 Mar; 67(3):391-5. PubMed ID: 16475190
[TBL] [Abstract][Full Text] [Related]
13. The impact of Sirolimus Eluting stents in interventional cardiology.
Di Mario C; Griffiths H; O'Rourke B; Kaddoura S
Int J Cardiol; 2004 Jun; 95(2-3):117-21. PubMed ID: 15193808
[No Abstract] [Full Text] [Related]
14. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
15. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
[TBL] [Abstract][Full Text] [Related]
16. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
Zhang F; Qian J; Ge J
J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
[TBL] [Abstract][Full Text] [Related]
17. Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
Watanabe T; Tamura A; Miyamoto K; Kadota J
Int J Cardiol; 2010 Apr; 140(1):e12-3. PubMed ID: 19059662
[TBL] [Abstract][Full Text] [Related]
18. Multiple stent strut fracture-induced restenosis in a diffuse long lesion treated with overlapping heterogeneous drug-eluting stent.
Kang WC; Moon C; Ahn TH; Shin EK
Int J Cardiol; 2008 Oct; 130(1):e30-3. PubMed ID: 17889952
[TBL] [Abstract][Full Text] [Related]
19. Oral rapamycin in the treatment of diffuse proliferative in-stent restenosis in a patient with small reference vessel.
Rodriguez AE; Fernández Pereira C; Rodríguez Alemparte M
J Invasive Cardiol; 2003 Sep; 15(9):515-8. PubMed ID: 12947212
[No Abstract] [Full Text] [Related]
20. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
